glp-1 next generation Orals and Multi-Agonists: Advancing Next-Gen Weight Loss Therapies with Humanized Models GLP-1S | Next Gen Peptides

Curious to learn more about the effect of GLP-1 on appetite, in 1998 Holst and collaborators at the University of Copenhagen undertook a placebo-controlled, randomised study with 20 healthy young men between the ages of 20 and 31

Most people who take GLP-1 drugs give themselves weekly or daily injections

Clinical trials have shown that discontinuing treatment typically results in gradual weight regain and worsening glycemic control, underscoring that these are chronic disease management tools rather than short-term interventions

There is no single solution for all patients, Ali said

Medically reviewed by Kristianne Hannemann, PharmD

This effect has been observed in several cardiovascular outcome clinical trials